Literature DB >> 4156639

Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide.

N P Plotnikoff, A J Kastin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4156639

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  3 in total

1.  Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Authors:  T Caraceni; E A Parati; F Girotti; I Celano; C Frigerio; D Cocchi; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

2.  Plasma beta-lipotropin levels in Parkinson's disease.

Authors:  M Wiesen; M D Yahr; D T Krieger
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

3.  Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1).

Authors:  Reas S Khan; Chuanhui Yu; Abba J Kastin; Yi He; Rudolph H Ehrensing; Hung Hsuchou; Kirsten Prufer Stone; Weihong Pan
Journal:  Int J Pept       Date:  2010-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.